Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific is a global giant that provides the essential tools, chemicals, and laboratory equipment scientists need to conduct medical research.
Is Thermo Fisher Scientific Inc. a good stock for a UK beginner?
The honest version: Thermo Fisher Scientific is a global giant that provides the essential tools, chemicals, and laboratory equipment scientists need to conduct medical research.
Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. And it's the USD return - as a UK investor your actual £ return also moves with the exchange rate. Past performance is not a guide to the future, and it could just as easily have fallen.
Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
Long-term expansion in global medical testing and drug discovery
Increased competition leading to lower profit margins
What does Thermo Fisher Scientific Inc. do?
Think of Thermo Fisher as the 'picks and shovels' provider for the healthcare industry; they supply everything from high-tech microscopes to the chemicals used in drug development. Those supplies sold to pharmaceutical companies, hospitals, and universities worldwide generate the income. What really drives the business is how much these organisations spend on research and development, since that dictates how many test tubes and machines Thermo Fisher sells.
On our factor screen it looks strongest on income and momentum, and weakest on value.
- ✓Pays a dividend - about 0.3% a year
- ✓Growing - revenue up about 10% over the year
- ✓Very profitable - turns about 15% of sales into profit
- !High P/E of 31 - big growth is already priced in
- Dominant market position in scientific supplies
- Diverse customer base across academia and industry
- Strong profit margins indicating efficient operations
- Potential for government spending cuts on healthcare
- Supply chain disruptions for specialised equipment
- Regulatory hurdles for new medical products
What do Thermo Fisher Scientific Inc.'s numbers mean?
How much money does Thermo Fisher Scientific Inc. make?
Revenue and profit by quarter, and how much of each sale turns into profit.
Does Thermo Fisher Scientific Inc. pay a dividend?
Yes - Thermo Fisher Scientific Inc. currently pays a dividend of about 0.3% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.
When does Thermo Fisher Scientific Inc. report earnings, and how did recent quarters go?
Thermo Fisher Scientific Inc. is next scheduled to report on about 2026-10-21 - dates can move, and we don't predict results; this just tells you when to look.
Each quarter a company reports its results against what analysts expected. ‘Beating’ or ‘missing’ is about that expectation, not whether the business is doing well in absolute terms.
| Reported | Expected EPS: The earnings per share analysts expected for the quarter - the average of their forecasts. 'Beating' or 'missing' is measured against this number. | Actual EPS | vs expected |
|---|---|---|---|
| 2026-07-23 | $5.71 | $6.03 | Beat +6% |
| 2026-04-23 | $5.24 | $5.44 | Beat +4% |
| 2026-01-29 | $6.45 | $6.57 | Beat +2% |
| 2025-10-22 | $5.50 | $5.79 | Beat +5% |
| 2025-07-23 | $5.23 | $5.36 | Beat +3% |
| 2025-04-23 | $5.10 | $5.15 | In line |
Across the last 6 quarters here, Thermo Fisher Scientific Inc. came in ahead of what analysts expected 5 times. One quarter is noise, not a trend.
See who else reports over the next two weeks →
Reported vs expected earnings per share (EPS) from published results; the expectation is the analyst consensus, not our view. Report dates are estimates that can move.
More in Healthcare
Eli Lilly
West Pharmaceutical Services, Inc.
Incyte Corporation
The Cigna Group
Zimmer Biomet Holdings, Inc.
Moderna, Inc.
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.What are the scenarios for Thermo Fisher Scientific Inc.?
An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.
What are the pros and cons of Thermo Fisher Scientific Inc.?
How many points the write-up makes each way — a balance check, not a score or verdict.
- Dominant market position in scientific supplies
- Diverse customer base across academia and industry
- Strong profit margins indicating efficient operations
- High valuation compared to some other sectors
- Very small dividend yield for income-focused investors
- Reliance on external research budgets
- Potential for government spending cuts on healthcare
- Supply chain disruptions for specialised equipment
- Regulatory hurdles for new medical products
The write-up's own warning lights — if these start happening, the case above changes.
- A significant, sustained decline in global pharmaceutical research spending
- The emergence of a disruptive competitor that makes their core equipment obsolete
Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-01 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.